Goldman Sachs’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

Goldman Sachs’s Portfolio HAAC Stock Details HAAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-514,390	Closed	-$5.14M	–	6593
2022 Q3	$5.14M	Sell	514,390 -394,898	-43%	-$3.92M	﹤0.01%	3111
2022 Q2	$8.98M	Sell	909,288 -306,028	-25%	-$3.02M	﹤0.01%	2617
2022 Q1	$12M	Buy	1,215,316 +3,236	+0.3%	+$31.7K	﹤0.01%	2507
2021 Q4	$11.8M	Buy	1,212,080 +3,722	+0.3%	+$36.5K	﹤0.01%	2604
2021 Q3	$11.8M	Sell	1,208,358 -50,990	-4%	-$499K	﹤0.01%	2560
2021 Q2	$12.6M	Buy	1,259,348 +116,746	+10%	+$1.19M	﹤0.01%	2479
2021 Q1	$11.7M	Buy	+1,142,602	New	+$13.5M	﹤0.01%	2425

Other funds holding HAAC

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Goldman Sachs's HAAC Position: Q4 2022 in Review

Goldman Sachs sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q4 2022, closing a stake of 514,390 shares — an estimated $5.14M sold.

Goldman Sachs first reported a position in HAAC in Q1 2021 and held it in 7 quarters. The position peaked at $12.6M in Q2 2021. 1 fund tracked by Wall St. Rank holds HAAC as of Q4 2022.

Goldman Sachs reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Goldman Sachs sold 514,390 Health Assurance Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $5.14M.
Goldman Sachs first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
Goldman Sachs's Health Assurance Acquisition Corp. Class A Common Stock position peaked at $12.6M in Q2 2021.
1 fund tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.